Home/All Molecules/Salmeterol

Salmeterol Range

Comprehensive Salmeterol portfolio for Franchise & Manufacturing.

Category
salmeterol
Total Formulations
8
Available Forms
Capsule, Inhaler, Rota Cap

Expand Your Business with Our Multiple Divisions


Browse Salmeterol portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Salmeterol batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Salmeterol PCD Pharma Franchise

Salmeterol PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Salmeterol PCD pharma franchise company offering a portfolio of 8 Salmeterol formulations across inhalers, rotacaps and capsules. Every batch is manufactured at DCGI-approved facilities and supplied to franchise partners with district-level monopoly rights, ready-to-use promotional inputs and dependable stock availability.

What is Salmeterol?

Salmeterol is a long-acting beta-2 adrenergic agonist (LABA). Its long lipophilic side chain anchors it in the beta-2 receptor domain, giving bronchodilation lasting around twelve hours. It is a maintenance controller, not a rescue medicine, and in asthma it must always be used together with an inhaled corticosteroid. The compound record can be reviewed on PubChem.

Therapeutic Applications

Maintenance therapy of asthma in combination with an inhaled corticosteroid such as fluticasone, and maintenance bronchodilation in chronic obstructive pulmonary disease. It is not indicated for relief of acute bronchospasm.

Prescribed by: Pulmonologists and chest physicians lead Salmeterol prescribing, with general physicians and paediatricians continuing maintenance therapy once initiated.

Why Salmeterol is a High-Potential Molecule for Distributors

Salmeterol is a controller rather than a reliever, so it is prescribed as continuous daily maintenance and produces the monthly refill behaviour that distributors value far more than episodic reliever sales. Almost all of its volume moves as a fixed-dose combination with fluticasone, which raises per-unit value well above a plain bronchodilator. As Indian respiratory practice shifts toward guideline-based controller therapy rather than reliever-only management, LABA-ICS combinations are the segment absorbing that growth.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers its Salmeterol franchise partners genuine monopoly rights for their allotted district or territory, products manufactured in WHO-GMP certified, DCGI-approved units, and complete promotional support — visual aids, MR bags, sample packs, product cards and doctor gifting. With 1000+ channel partners across India, on-time dispatch and transparent net rates, we make it straightforward to build a profitable Salmeterol business in your region.

References

  1. PubChem – Salmeterol compound record, US National Library of Medicine
  2. PubMed – clinical literature on Salmeterol, NCBI

Aceclofenac in Modern Clinical Practice

Our formulations of Salmeterol find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Salmeterol in PCD Franchise

Start Your Salmeterol Franchise with Cafoli Lifecare

Ready to take monopoly rights for Salmeterol in your district? Talk to our franchise team for net rates, packing details and the current availability list. Call 9518447302 or email info@cafoli.in.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 8 Salmeterol formulations in inhalers, rotacaps and capsules. The current list with packing and net rates is shared with registered franchise enquiries.

Yes. Monopoly rights for the Salmeterol range are allotted district-wise on a first-come basis and are confirmed in your franchise agreement, so no other Cafoli partner sells the same brands in your territory.

Pulmonologists and chest physicians lead Salmeterol prescribing, with general physicians and paediatricians continuing maintenance therapy once initiated.

Used alone in asthma, a long-acting beta-2 agonist can relieve symptoms without treating the underlying airway inflammation, which is why guidelines require it to be given with an inhaled corticosteroid. Commercially this is why nearly all Salmeterol volume moves as a fluticasone-salmeterol combination inhaler or rotacap rather than as a single-agent product.

You need a valid Drug License and a GST registration in your name. Once these are shared along with your territory preference, the Salmeterol franchise agreement and monopoly allotment can be processed.